Çağatay TAŞKAPAN, Nevzat ERDİL, Olcay Murat DİŞLİ, Mehmet Beşir AKPINAR, Serkan SEÇİCİ, Ahmet Feyzi ABACILAR, İhsan Sami UYAR, Bektaş BATTALOĞLU

Rosuvastatin ön tedavisi koroner arter baypas greftleme sonrasında mikroalbuminüriyi azaltmaz

Amaç: Bu çalışmada rosuvastatinin, kardiyopulmoner baypas (KPB) eşliğinde yapılan koroner arter baypas greftleme (KABG) sonrasında mikroalbuminüriyi azaltıp azaltmadığı araştırıldı.Çalışma planı: Bu prospektif çalışmaya izole KABG yapılan toplam 40 hasta (37 erkek, 3 kadın; ort. yaş 59.0±10.1 yıl; dağılım 48-78 yıl) alındı. Hastalar kontrol grubu (n=20) ve elektif KABG'den yedi gün önce 20 mg/gün rosuvastatin kullanmış hastalardan oluşan rosuvastatin grubu (n=20) olarak ikiye ayrıldı. Tüm hastalardan mikroalbuminüri idrar sondası takıldığında, KPB'nin başlangıcından önce, KPB'nin sonlandırıldığı anda ve yoğun bakım ünitesinde altıncı ve 24. saatlerde spot idrar örneği ile ölçüldü. Serum C-reaktif protein ise anestezi indüksiyonundan önce ve yoğun bakım ünitesinde altıncı ve 24. saatte kan örneği ile ölçüldü.Bul gu lar: Hastaların demografik verileri ve ameliyat öncesi özellikleri benzerdi. Gruplar arasında KPB, kros klemp ve ameliyat süreleri, inotrop desteği, ekstübasyon süreleri ve hastaneden taburculuk süreleri arasında anlamlı fark bulunmadı. Üriner albümin/kreatinin oranları her iki grupta başlangıç ölçümüne kıyasla artmıştı ve KPB sonunda maksimum düzeye ulaştı (p

Rosuvastatin pretreatment does not attenuate microalbuminuria after coronary artery bypass grafting

Background: This study aims to evaluate whether rosuvastatin attenuates microalbuminuria following coronary artery bypass grafting (CABG) with a cardiopulmonary bypass (CPB). Methods: This prospective study was performed in 40 patients (37 males, 3 females; mean age 59.0±10.1 years; range 48 to 78 years) who were scheduled for isolated CABG. The patients were divided into two groups including control group (n=20) and rosuvastatin group (n=20) which received rosuvastatin 20 mg/day seven day (20 mg/day) before elective CABG. Microalbuminuria was measured after the insertion of the urinary catheter, before CPB, after the termination of CPB, and at the sixth and 24th hours in the intensive care unit using a spot urine sample. Serum C-reactive protein was measured before the induction of anesthesia and at the sixth and 24th hours in the intensive care unit using blood samples. Results: The demographic data and preoperative characteristics of the patients were similar. There were no significant differences in the CPB, cross-clamp and surgery time, inotropic support, extubation times, and time to discharge from hospital between the two groups. The urinary albumin/creatinine ratio increased in both groups, compared to the baseline measurement and reached a maximum level at the end of CPB (p

PDF

___

1. Harmoinen A, Kaukinen L, Porkkala T, Tarkka M, Kaukinen S. Off-pump surgery does not eliminate microalbuminuria or other markers of systemic inflammatory response to coronary artery bypass surgery. Scand Cardiovasc J 2006;40:110-6.
2. Hokenek F, Gursoy M, Bakuy V, Kavala AA, Demir T, Gulcan F, et al. An evaluation of renal functions in pulsatile and non-pulsatile cardiopulmonary bypass in the elderly. Turk Gogus Kalp Dama 2013;21:610-5.
3. Fuertes Guiro F, d'Urbano C. Usefulness of microalbuminuria in early prediction of acute respiratory distress failure in the polytraumatized patient. Emergencia 1999;11:19-25.
4. Smith FC, Gosling P, Sanghera K, Green MA, Paterson IS, Shearman CP. Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery. Ann Vasc Surg 1994;8:1-5.
5. Hickey NC, Shearman CP, Gosling P, Simms MH. Assessment of intermittent claudication by quantitation of exerciseinduced microalbuminuria. Eur J Vasc Surg 1990;4:603-6.
6. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-9.
7. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003;23:729-36.
8. Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agrò F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660-7.
9. Dotani MI, Elnicki DM, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000;86:1128-30.
10. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110:II45-9.
11. Uysal OK, Sahin DY, Koc M, Duran M, Ozkan B, Tekin K, et al. Evaluation of the relationship between the levels of high-sensitivity C-reactive protein and saphenous vein graft disease. Turk Gogus Kalp Dama 2013;21:268-75.
12. Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 2000;102:3104-10.
13. van Nieuw Amerongen GP, Vermeer MA, Nègre-Aminou P, Lankelma J, Emeis JJ, van Hinsbergh VW. Simvastatin improves disturbed endothelial barrier function. Circulation 2000;102:2803-9.
14. Raijmakers PG, Groeneveld AB, Teule GJ, Thijs LG. Diagnostic value of the gallium-67 pulmonary leak index in pulmonary edema. J Nucl Med 1996;37:1316-22.
15. Groeneveld AB, Raijmakers PG, Teule GJ, Thijs LG. The 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. Crit Care Med 1996;24:1467-72.
16. Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms. Stroke 2004;35:2708-11.
17. Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 2002;91:173-9.
18. van de Visse EP, van der Heijden M, Verheij J, van Nieuw Amerongen GP, van Hinsbergh VW, Girbes AR, et al. Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery. Eur Respir J 2006;27:1026-32.
19. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114:1455-61.
20. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008;136:1541-8